CRISPR And CRISPR-Associated Genes Market, Global Outlook and Forecast 2023-2029

Report ID: MMG70872 | Category: Medical Care | Pages: 109 | Format: PDF | Published Date: March 06,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. 
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
This report aims to provide a comprehensive presentation of the global market for CRISPR And CRISPR-Associated Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR And CRISPR-Associated Genes. This report contains market size and forecasts of CRISPR And CRISPR-Associated Genes in global, including the following market information:
Global CRISPR And CRISPR-Associated Genes Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global CRISPR And CRISPR-Associated Genes market was valued at US$ 1424.5 million in 2022 and is projected to reach US$ 1794 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRISPR And CRISPR-Associated Genes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR And CRISPR-Associated Genes Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global CRISPR And CRISPR-Associated Genes Market Segment Percentages, by Type, 2022 (%)
    Genome Editing
    Genetic Engineering
    GRNA Database/Gene Librar
    CRISPR Plasmid
    Human Stem Cells
    Genetically Modified Organisms/Crops
    Cell Line Engineering
Global CRISPR And CRISPR-Associated Genes Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global CRISPR And CRISPR-Associated Genes Market Segment Percentages, by Application, 2022 (%)
    Biotechnology Companies
    Pharmaceutical Companies
    Academic Institutes
    Research and Development Institutes
Global CRISPR And CRISPR-Associated Genes Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global CRISPR And CRISPR-Associated Genes Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR And CRISPR-Associated Genes revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CRISPR And CRISPR-Associated Genes revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Thermo Fisher Scientific
    Editas Medicine
    Caribou Biosciences
    CRISPR therapeutics
    Intellia therapeutics, Inc.
    Cellectis
    Horizon Discovery Plc
    Sigma Aldrich
    Precision Biosciences
    Genscript
    Sangamo Biosciences Inc.
    Lonza Group Limited
    Integrated DNA Technologies
    New England Biolabs
    Origene Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of CRISPR And CRISPR-Associated Genes, market overview.
Chapter 2: Global CRISPR And CRISPR-Associated Genes market size in revenue.
Chapter 3: Detailed analysis of CRISPR And CRISPR-Associated Genes company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CRISPR And CRISPR-Associated Genes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 CRISPR And CRISPR-Associated Genes Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CRISPR And CRISPR-Associated Genes Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CRISPR And CRISPR-Associated Genes Overall Market Size
    2.1 Global CRISPR And CRISPR-Associated Genes Market Size: 2022 VS 2029
    2.2 Global CRISPR And CRISPR-Associated Genes Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CRISPR And CRISPR-Associated Genes Players in Global Market
    3.2 Top Global CRISPR And CRISPR-Associated Genes Companies Ranked by Revenue
    3.3 Global CRISPR And CRISPR-Associated Genes Revenue by Companies
    3.4 Top 3 and Top 5 CRISPR And CRISPR-Associated Genes Companies in Global Market, by Revenue in 2022
    3.5 Global Companies CRISPR And CRISPR-Associated Genes Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CRISPR And CRISPR-Associated Genes Players in Global Market
        3.6.1 List of Global Tier 1 CRISPR And CRISPR-Associated Genes Companies
        3.6.2 List of Global Tier 2 and Tier 3 CRISPR And CRISPR-Associated Genes Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global CRISPR And CRISPR-Associated Genes Market Size Markets, 2022 & 2029
        4.1.2 Genome Editing
        4.1.3 Genetic Engineering
        4.1.4 GRNA Database/Gene Librar
        4.1.5 CRISPR Plasmid
        4.1.6 Human Stem Cells
        4.1.7 Genetically Modified Organisms/Crops
        4.1.8 Cell Line Engineering
    4.2 By Type - Global CRISPR And CRISPR-Associated Genes Revenue & Forecasts
        4.2.1 By Type - Global CRISPR And CRISPR-Associated Genes Revenue, 2018-2023
        4.2.2 By Type - Global CRISPR And CRISPR-Associated Genes Revenue, 2024-2029
        4.2.3 By Type - Global CRISPR And CRISPR-Associated Genes Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CRISPR And CRISPR-Associated Genes Market Size, 2022 & 2029
        5.1.2 Biotechnology Companies
        5.1.3 Pharmaceutical Companies
        5.1.4 Academic Institutes
        5.1.5 Research and Development Institutes
    5.2 By Application - Global CRISPR And CRISPR-Associated Genes Revenue & Forecasts
        5.2.1 By Application - Global CRISPR And CRISPR-Associated Genes Revenue, 2018-2023
        5.2.2 By Application - Global CRISPR And CRISPR-Associated Genes Revenue, 2024-2029
        5.2.3 By Application - Global CRISPR And CRISPR-Associated Genes Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global CRISPR And CRISPR-Associated Genes Market Size, 2022 & 2029
    6.2 By Region - Global CRISPR And CRISPR-Associated Genes Revenue & Forecasts
        6.2.1 By Region - Global CRISPR And CRISPR-Associated Genes Revenue, 2018-2023
        6.2.2 By Region - Global CRISPR And CRISPR-Associated Genes Revenue, 2024-2029
        6.2.3 By Region - Global CRISPR And CRISPR-Associated Genes Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America CRISPR And CRISPR-Associated Genes Revenue, 2018-2029
        6.3.2 US CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.3.3 Canada CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.3.4 Mexico CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe CRISPR And CRISPR-Associated Genes Revenue, 2018-2029
        6.4.2 Germany CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.4.3 France CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.4.4 U.K. CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.4.5 Italy CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.4.6 Russia CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.4.7 Nordic Countries CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.4.8 Benelux CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia CRISPR And CRISPR-Associated Genes Revenue, 2018-2029
        6.5.2 China CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.5.3 Japan CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.5.4 South Korea CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.5.5 Southeast Asia CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.5.6 India CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America CRISPR And CRISPR-Associated Genes Revenue, 2018-2029
        6.6.2 Brazil CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.6.3 Argentina CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CRISPR And CRISPR-Associated Genes Revenue, 2018-2029
        6.7.2 Turkey CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.7.3 Israel CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.7.4 Saudi Arabia CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
        6.7.5 UAE CRISPR And CRISPR-Associated Genes Market Size, 2018-2029
7 CRISPR And CRISPR-Associated Genes Companies Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Company Summary
        7.1.2 Thermo Fisher Scientific Business Overview
        7.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.1.4 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.1.5 Thermo Fisher Scientific Key News & Latest Developments
    7.2 Editas Medicine
        7.2.1 Editas Medicine Company Summary
        7.2.2 Editas Medicine Business Overview
        7.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.2.4 Editas Medicine CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.2.5 Editas Medicine Key News & Latest Developments
    7.3 Caribou Biosciences
        7.3.1 Caribou Biosciences Company Summary
        7.3.2 Caribou Biosciences Business Overview
        7.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.3.4 Caribou Biosciences CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.3.5 Caribou Biosciences Key News & Latest Developments
    7.4 CRISPR therapeutics
        7.4.1 CRISPR therapeutics Company Summary
        7.4.2 CRISPR therapeutics Business Overview
        7.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.4.4 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.4.5 CRISPR therapeutics Key News & Latest Developments
    7.5 Intellia therapeutics, Inc.
        7.5.1 Intellia therapeutics, Inc. Company Summary
        7.5.2 Intellia therapeutics, Inc. Business Overview
        7.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.5.4 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.5.5 Intellia therapeutics, Inc. Key News & Latest Developments
    7.6 Cellectis
        7.6.1 Cellectis Company Summary
        7.6.2 Cellectis Business Overview
        7.6.3 Cellectis CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.6.4 Cellectis CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.6.5 Cellectis Key News & Latest Developments
    7.7 Horizon Discovery Plc
        7.7.1 Horizon Discovery Plc Company Summary
        7.7.2 Horizon Discovery Plc Business Overview
        7.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.7.4 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.7.5 Horizon Discovery Plc Key News & Latest Developments
    7.8 Sigma Aldrich
        7.8.1 Sigma Aldrich Company Summary
        7.8.2 Sigma Aldrich Business Overview
        7.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.8.4 Sigma Aldrich CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.8.5 Sigma Aldrich Key News & Latest Developments
    7.9 Precision Biosciences
        7.9.1 Precision Biosciences Company Summary
        7.9.2 Precision Biosciences Business Overview
        7.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.9.4 Precision Biosciences CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.9.5 Precision Biosciences Key News & Latest Developments
    7.10 Genscript
        7.10.1 Genscript Company Summary
        7.10.2 Genscript Business Overview
        7.10.3 Genscript CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.10.4 Genscript CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.10.5 Genscript Key News & Latest Developments
    7.11 Sangamo Biosciences Inc.
        7.11.1 Sangamo Biosciences Inc. Company Summary
        7.11.2 Sangamo Biosciences Inc. Business Overview
        7.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.11.4 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.11.5 Sangamo Biosciences Inc. Key News & Latest Developments
    7.12 Lonza Group Limited
        7.12.1 Lonza Group Limited Company Summary
        7.12.2 Lonza Group Limited Business Overview
        7.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.12.4 Lonza Group Limited CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.12.5 Lonza Group Limited Key News & Latest Developments
    7.13 Integrated DNA Technologies
        7.13.1 Integrated DNA Technologies Company Summary
        7.13.2 Integrated DNA Technologies Business Overview
        7.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.13.4 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.13.5 Integrated DNA Technologies Key News & Latest Developments
    7.14 New England Biolabs
        7.14.1 New England Biolabs Company Summary
        7.14.2 New England Biolabs Business Overview
        7.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.14.4 New England Biolabs CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.14.5 New England Biolabs Key News & Latest Developments
    7.15 Origene Technologies
        7.15.1 Origene Technologies Company Summary
        7.15.2 Origene Technologies Business Overview
        7.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Major Product Offerings
        7.15.4 Origene Technologies CRISPR And CRISPR-Associated Genes Revenue in Global Market (2018-2023)
        7.15.5 Origene Technologies Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

CRISPR And CRISPR-Associated Genes Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?